ECFI Medicinal products for human use – Procedure for designation of orphan medicinal products – Application for designation of human fibrinogen as an orphan medicinal product – Obligation to submit the application for designation before the application for marketing authorisation is made – Decision of EMA on the validity of the application.
Citations:
T-264/07, [2010] EUECJ T-264/07
Links:
European
Updated: 24 August 2022; Ref: scu.424166